IQVIA Holdings | IQV - Прибыль до налогообложения





Прибыль до налогообложения Изменить Дата
Accenture USD 2.46B 511.02M 2025-12
Agilent USD 364M 78M 2025-12
Bruker USD 68.2M 140.8M 2025-12
Cardinal Health USD 630M 32M 2025-12
Celltrion KRW 10.5B 4.1B 2025-12
Charles River Laboratories USD -294.1M 464.13M 2025-12
Cigna USD 1.82B 478M 2025-12
Cognizant Technology Solutions USD 15.07B 53.04M 2026-03
Cspc Pharmaceutical CNY 505.59M 706M 2025-12
CVS Health USD 3.94B 2.58B 2026-03
Danaher USD 1.24B 138M 2026-03
Dentsply International USD -42M 105M 2026-03
Dianthus Therapeutics USD -64.43M 27.67M 2025-12
Divis Laboratories Ltd INR 9.63B 1.09B 2026-03
Elevance Health USD 215M 1.19B 2025-12
Humana USD -1.01B 1.54B 2025-12
IBM USD 2.13B 2.01B 2026-03
Illumina USD 157M 220M 2026-03
Infosys INR 107.47B 15.6B 2026-03
Kangmei Pharma CNY -14.01M 16.08M 2026-03
Knight Therapeutics CAD -1.92M 13.69M 2025-09
Laboratorios Farma EUR 26.78M 94.77M 2025-06
Laboratory Of America USD 8.73B 8.54B 2026-03
McKesson USD 1.63B 235M 2025-12
Mettler Toledo International USD 329.07M 59.84M 2025-12
Organigram Holdings CAD -41.72M 25.52M 2025-09
Pharma Mar EUR 1.6M 38.6M 2026-03
Publicis EUR 549M 487M 2025-06
Qiagen NV USD 109.17M 25.56M 2025-12
Quest Diagnostics USD 334M 4M 2026-03
Revvity USD 91.56M 35.88M 2025-12
Sartorius EUR 157.8M 76.1M 2026-03
Thermo Fisher Scientific USD 2.12B 295M 2025-12
Tilray USD -39.96M 39.19M 2025-09
UnitedHealth USD -720M 3.95B 2025-12
Veeva Systems USD 469.79M 152.26M 2026-03
Veradigm USD 35.3M 13.95M 2022-09
Waters USD 264.18M 94.06M 2025-12
Zealand Pharma A/S -406.5M 39.77M 2025-12
Zz Pientze Pharmaceu CNY 876.07M 352.96M 2026-03